Boosting sustainable consumption and behaviour
The Ecocheque, a Belgian practice involving employers into public policy
//-->
European Policy Response to Metastatic Breast Cancer
Tuesday 17th October 2017, 12.00-14.00 CET
European Parliament, Rue Wiertz 60, Brussels
Altiero Spinelli Building (ASP) - Room AE3
Breast cancer is the most prevalent form of cancer in women today, with a rising incidence worldwide. Metastatic breast cancer in particular is incurable, and is responsible for half a million premature deaths worldwide each year. Despite significant progress made during the last decade, there are still many areas in which further action is required.
In this context, a metastatic breast cancer policy roadmap has been developed by a multi-disciplinary working group of experts with a view to making practical and actionable recommendations to policymakers across Europe.
On October 17th, we will be discussing how to improve the policy response to metastatic breast cancer in Europe, focusing on the priorities identified in this policy roadmap. On behalf of the working group, I invite you to join us in this debate and engage with scientific, advocacy and policy experts in an effort to advance policy changes that will improve the lives of patients suffering from metastatic breast cancer.
Registration before 10 October 2017 is mandatory.
12h00 |
Welcome and introduction Ms. Karin Kadenbach, MEP S&D Group, Member of the ENVI Committee
Mr. Alberto Cirio, MEP EPP Group, Member of the ENVI Committee |
12h05 |
European Parliament perspective on metastatic breast cancer Ms. Adina VĀLEAN, Chairwoman of the ENVI Committee, European Parliament |
12h20 |
Differentiation between early breast cancer and metastatic breast cancer: a clinical perspective Dr. Fatima Cardoso MD, Director of the Breast Unit of the Champalimaud Clinical Center in Lisbon Video message |
12h30 |
European policy on metastatic breast cancer Ms. Luciana Neamțiu, Joint Research Centre European Commission Initiative on Breast Cancer |
12h45 |
Living with metastatic breast cancer: a patient perspective Ms. Suzanne Leempoels |
13h05 | Advancing policy changes to improve the lives of patients with metastatic breast cancer: presenting the policy roadmap Prof. Nils Wilking MD PhD, Practicing medical oncologist, Professor at the Karolinska Institute and Senior Strategic Advisor for the Southern Health Care Region in Sweden |
13h20 |
Panel discussion and Q&A from the audience: what can be done to improve the lives of people with metastatic breast cancer? Ms. Renate Haidinger - Patient rights representative and founding chairwoman of the German breast cancer association Ms. Luciana Neamțiu, JRC Healthcare Quality and ECIBC Team Mr. François Ringeisen MD PhD, Medical Fellow/ International BU Medical Lead Breast Cancer, Eli Lilly & Company Ms. Emma Woodford, Chief Operating Officer for the European Oncology Nursing Society Moderated by: Ms. Karin Kadenbach, MEP S&D Group, Member of the ENVI Committee |
13h50 |
Closing comments Mr. Alberto Cirio, MEP EPP Group, Member of the ENVI Committee |
Boosting sustainable consumption and behaviour
The Ecocheque, a Belgian practice involving employers into public policy
The current debate on the next EU Framework Programme for Research and Innovation (FP9) offers the opportunity to articulate a long-term vision for biomedical and health research, and to address current gaps in support of excellent science.
On Tuesday, March 20th, 2018, the Global Sepsis Alliance, jointly with EU Commissioner for Health and Food Safety, Vytenis Andriukaitis, will host the event 'Sepsis - The Most Prev
Big data is revolutionising healthcare and it is at our fingertip! Find out how to get onboard the movement that is fast transforming the way we live and work!
The European Cancer Patient Coalition, together with MEP Marlene Mizzi (S&D, Malta), is organising an event on the topic of Cancer Biomarkers in the Era of Personalised Medicines.
Ten years after the European Commission’s “White paper on a Strategy for Europe on Nutrition, Overweight and Obesity-related health issues”, the European Snacks Association gathers stakeholders to discuss the lessons learned and explore ways of building consensus on eff
There are currently over 200 million women living with diabetes and this total is projected to increase to more than 300 million by 2040. Diabetes is the ninth leading cause of death in women globally, causing 2.1 million deaths each year.
The Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium (BBMRI-ERIC) is hosting a seminar to assess the impact of the GDPR on FP9 health research and examine how the Code of Conduct for Health Research being developed by BBMRI-ERIC a
Hosted by MEP Heinz K. Becker (EPP, Austria)
Consumer rights
Sustainable agriculture, safer food, strong rural communities
At the European Parliament in Brussels in room A3G-3.
On Wednesday 27 September 2017 from 14h30 - 17h30.
On the 20th of June 2017, Brussels will become the capital of Flavour.
The European Parliament Interest Group on Allergy and Asthma invites you to the policy symposium “United Action for Allergy and Asthma” at the Europea
“European policy response to rare cancers: the case of sarcoma”
8th February 2017, 14h30-16h30
European Parliament, Altiero Spinelli building, room A5E-2, Brussels